Immunogenicity of a subviral herpes simplex type 1 preparation: reduction of recurrent disease in mice

Area of Science:

• Virology
• Immunology
• Vaccinology

Background:

• Herpes simplex virus type 1 (HSV-1) establishes lifelong infections, often leading to recurrent disease.
• Current treatments for HSV-1 focus on managing symptoms and reducing transmission, not preventing recurrences.

Purpose of the Study:

• To evaluate the efficacy of a subviral HSV-1 vaccine in preventing recurrent disease.
• To determine if the timing of vaccination impacts its effectiveness against HSV-1 recurrence.

Main Methods:

• Mice were immunized with a subviral HSV-1 vaccine at a specific dose.
• Vaccination was administered either before or after homotypic HSV-1 virus infection.
• The frequency of recurrent disease was monitored in all groups.

Main Results:

• Immunization prior to HSV-1 infection markedly decreased the incidence of recurrent disease.
• Administering the same vaccine dose after HSV-1 infection showed no significant reduction in recurrences.

Conclusions:

• Early-stage vaccination with a subviral HSV-1 vaccine is a promising strategy for preventing recurrent HSV-1 disease.
• Vaccine timing is critical for achieving therapeutic benefits against herpes simplex virus type 1 recurrences.